Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

NCT00455624 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00455624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
November 30, 2002
Completion date
May 31, 2006
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer